News

(Update with New Jersey Attorney General Jennifer Davenport's statement on the lawsuit in the penult

A European court rejected Broadcom's attempt to block regulators from demanding U.S.-based VMware legal documents.

California’s governor warns that an antitrust lawsuit threatening the media mega-merger could severely damage local entertainment industry jobs.

The California governor has told people involved in the suit that blocking the $81 billion deal could harm Hollywood jobs.

LONDON, July 27 (Reuters) - Elon Musk's Tesla on Monday won its bid to revive a London lawsuit brought against U.S. technology firm InterDigital and a patent licensing platform, seeking a patent

The new findings position Lilly to file an application for the highly anticipated medicine, but also leave some questions about the additive benefits a “triple-G” drug has on heart health.

Court strips shareholder case of class-action status

Investing.com -- Apple Inc. and the US Justice Department are in early discussions to settle a 2024 antitrust lawsuit, Bloomberg reported Friday.

Apple ‌and ‌the U.S. Department ​of Justice are in ‌early ⁠discussions about settling ⁠a 2024 ​lawsuit ​that ​alleges the ‌iPhone maker violated antitrust laws, ‌Bloomberg ​News ​reported ​on ‌Friday. Reuters could not ​immediately ​verify the ​report. (Reporting ‌by Jaspreet ​Singh in ​Bengaluru)

(Bloomberg) -- Apple Inc. and the US Justice Department are in early discussions about settling a 2024 lawsuit that alleges the iPhone maker violated antitrust laws. Most Read from BloombergFCC Near Rulings Against Disney Over ‘The View,’ TV LicensesChip Stocks Poised for Bear Market in AI Unwind: Markets WrapGoogle Gemini Launch Delayed as Tech Falls Short of Internal GoalsChina’s Moonshot Unveils AI Model That Narrows Gap With US FirmsThailand Scraps Plan to End Visa-Free Entry for Indian Tour

The daily medication is expected to be list-priced at $10.50 per pill. Here's what to know about Merck's new cholesterol drug Lipfendra.

Lipfendra, to be taken once a day, is designed to help lower cholesterol levels beyond what statins alone can achieve.

Just one day after glowing reviews, a surprise revenue warning sent the stock into a tailspin and brought lawyers to the door.

Still, shares fell by nearly 20% after the company revealed a delay in the coming launch of Revtorpyk. Details in the drug’s prescribing information surprised some analysts, too.

Alphabet unit Google on Wednesday urged Europe's top court to dismiss EU antitrust regulators' appeal ‌against a lower court ruling that scrapped a €1.49 billion ($1.7 billion) fine, saying ‌the regulators' arguments were flawed. The dispute reached the Court of Justice of the European Union ​after regulators appealed a 2024 General Court ruling that annulled the fine imposed on Google in 2019. The lower court cited errors in the European Commission's assessment of the case.

Gedatolisib, in-licensed from Pfizer in 2021, is Celcuity’s sole late-stage asset.

Carr expressed his views on the Paramount-Warner Bros. Discovery merger, antitrust concerns and Disney’s DEI-related investigations.

PARIS, July 8 (Reuters) - France's competition authority on Wednesday ordered Meta Platforms to resume talks with French media groups over payments for publishing content, after the publishers

Ford ranked No. 1 among mass-market brands in J.D. Power's initial quality study.

The judgment concludes a legal dispute that began after the European Commission fined Google in 2018 for abusing market dominance.

Alphabet Inc (NASDAQ:GOOG) shares traded about 1% lower on Thursday after the European Court of Justice (ECJ) upheld a €4.1 billion ($4.67 billion) antitrust fine against Google over its Android mobile operating system. The ruling marks the end of Google's legal challenge against the European...

EU court backs regulators in long-running case.

Europe's top court upheld findings that Google abused Android's market dominance.

On this episode of Stock Movers: - SoftBank (SFTBY) shares are responding to news that it is starting a new U.S. venture to rent out the computing power needed to build and run artificial-intelligence models, aiming to capitalize on strong American demand for AI computing resources. - Shares of Alphabet/Google (GOOG) are responding to the company losing its long-running fight against a 4.1 billion ($4.7 billion) European Union antitrust fine after the bloc's top judges said regulators were right to punish the US giant for abusing Android's market power.

Alphabet's Google on Thursday lost its fight against a record fine imposed by ‌EU antitrust regulators eight years ago for using its Android mobile operating ‌system to block rivals, a court ruling likely to boost Europe's crackdown on Big Tech. The European ​Commission had originally handed out a €4.34 billion fine to Google in 2018 for its agreements which forced phone manufacturers to pre-install Google Search, the Chrome browser and the Google Play app store on their Android devices and prevented them from using rival ‌Android systems. Google then appealed ⁠to the Luxembourg-based Court of Justice of the European Union, Europe's highest.

Yahoo Finance Tech Editor Dan Howley breaks down some of the day's biggest headlines, including Alphabet's Google (GOOG, GOOGL) being ordered by a Swedish court to pay nearly $2 billion to buy now, pay later platform Klarna (KLAR) in an antitrust suit.

South Korea's antitrust regulator accused Google of abusing its dominance in the Android app market.

By Supantha Mukherjee STOCKHOLM, July 1 (Reuters) - A Swedish court on Wednesday ordered Alphabet's Google to pay about $1.5 billion in damages to PriceRunner, the price comparison business owned by

A Swedish court determines the Alphabet-owned tech giant favored its own shopping service in search results.

The Patent and Market Court in Stockholm ruled Google unlawfully favored its own shopping comparison service, though the award fell well short of what PriceRunner sought